NJ
Nimish Jindal Dirigeant
Other
IN IN · SEBI (PIT + SAST)
Discover the detailed record of transactions filed by Nimish Jindal, Dirigeant. Officer active across 1 companies, notably Dr. Lal Path Labs Ltd.. In total, 30 reports have been recorded. The latest transaction was disclosed on 3 June 2025 — Sale. Regulator: SEBI (PIT + SAST). All data is free.
Declarations 30 total
€2,898 100 shares @ €28.982
Equity Shares
SEBI:b3321cc4dea65efae5597bcd20f5e15d8d78009f · 3 Jun 2025
€11,053 500 shares @ €22.1061
Equity Shares
SEBI:3c08c350fc64c9739b0675ee5223a83640209bbd · 5 Jun 2025
Ideal exit: 2 Mar 2026 (T+270) €9,921 500 shares @ €19.8428
Equity Shares
SEBI:1d6f64ec8c4afcabdffcfdd6b3a122b1b756d716 · 30 May 2025
Ideal exit: 24 Feb 2026 (T+270) €39 375 shares @ €0.1033
Equity Shares
SEBI:2faa3a6db7626692f6de0bbc187ce37ed213ca4d · 27 May 2025
Ideal exit: 21 Feb 2026 (T+270) €16,319 550 shares @ €29.671
Equity Shares
SEBI:4be014441833f9acea241dfbfaa40221b15acf83 · 20 May 2025
€39 375 shares @ €0.1048
Equity Shares
SEBI:b460d67117b11a1c0c625b36493deac3152e3646 · 13 May 2025
Ideal exit: 7 Feb 2026 (T+270) €63 575 shares @ €0.1101
Equity Shares
SEBI:62d5a1cf525abc94d9b39de9e9b8f3cde71a5eb0 · 3 Mar 2025
Ideal exit: 28 Nov 2025 (T+270) €75 675 shares @ €0.1114
Equity Shares
SEBI:acb99d35fadf15f558ff3bde64e6f16a513b50ab · 3 Feb 2025
Ideal exit: 31 Oct 2025 (T+270) €71 625 shares @ €0.1128
Equity Shares
SEBI:0fc73856d12683d1ee8a95b1b2c63bcca34c46c6 · 26 Dec 2024
Ideal exit: 22 Sept 2025 (T+270) €3,574 100 shares @ €35.7438
Equity Shares
SEBI:76a8f493dd395771925e451e301ece613257a11b · 10 Dec 2024
€42 375 shares @ €0.1119
Equity Shares
SEBI:61e566ac864ba40a0a9af12cf339b6d77af74bc8 · 17 Dec 2024
Ideal exit: 13 Sept 2025 (T+270) €10,915 300 shares @ €36.383
Equity Shares
SEBI:c6fb230410c5ba2dc19dc0f2721f8ac2468dea53 · 12 Sept 2024
€10,361 500 shares @ €20.7229
Equity Shares
SEBI:2d3c679a77df838e04c0f856f2b06dff97edbbd4 · 4 Sept 2024
Ideal exit: 1 Jun 2025 (T+270) €14,714 400 shares @ €36.785
Equity Shares
SEBI:f84ff17773864b3089104a72deb3ad3ea6d47700 · 30 Aug 2024
€14,643 408 shares @ €35.8907
Equity Shares
SEBI:9f4359d221e62062a87439415a391e4dec5942e4 · 20 Aug 2024
€24,694 692 shares @ €35.6851
Equity Shares
SEBI:f45af9b2bf1c881bd461caa0bb84aa143974a08c · 16 Aug 2024
€12,315 350 shares @ €35.187
Equity Shares
SEBI:063b40451ab07ed856a4aef1cd79b69b982d13f0 · 12 Aug 2024
€16,843 575 shares @ €29.2927
Equity Shares
SEBI:1afa1ed94786efaf0578512dbd0643291a80d584 · 17 May 2024
€83 750 shares @ €0.1104
Equity Shares
SEBI:05a603c7bc26763ca1ae221cae3937170acbfb47 · 12 Mar 2024
Ideal exit: 7 Dec 2024 (T+270) €17,372 575 shares @ €30.2126
Equity Shares
SEBI:f49a7971693ecae676546f636499e0a5a2992494 · 6 Nov 2023
€138 1,225 shares @ €0.1125
Equity Shares
SEBI:0faf3f4e8220c201b01a0bf788b279b53702ddf3 · 7 Feb 2023
Ideal exit: 4 Nov 2023 (T+270) €18,176 550 shares @ €33.0467
Equity Shares
SEBI:cade26ef6564e3109b7147ce56896c4c7c334e2d · 26 Sept 2022
€7,196 225 shares @ €31.9821
Equity Shares
SEBI:c94ba7d24f1f77fb25bbab82adc33c63cee7ada5 · 25 Aug 2022
€85 675 shares @ €0.1252
Equity Shares
SEBI:b3e120afe9c2654a4a75076f8a09592fdd6a4465 · 8 Sept 2022
Ideal exit: 5 Jun 2023 (T+270) €93 775 shares @ €0.1201
Equity Shares
SEBI:86d0a9d18da9298d5043c9d3220b2a8107dfdf0e · 24 May 2022
Ideal exit: 18 Feb 2023 (T+270) 25 of 30 declarations
Load more (5 remaining) About Nimish Jindal Nimish Jindal is an executive at Dr. Lal Path Labs Ltd. He plays a key role in managing laboratory operations and improving diagnostic services. His expertise contributes to the quality of healthcare provided by the company.